American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025

The American Academy of Child and Adolescent Psychiatry (AACAP) Pediatric Psychopharmacology Update Institute 2025 is an advanced educational program delivering the latest evidence-based knowledge on the use of psychotropic medications in children and adolescents. Presented by leading experts in psychiatry and pharmacology, this course blends cutting-edge research with practical, clinically relevant guidance to enhance prescribing practices, ensure patient safety, and improve treatment outcomes for young patients.
What You Will Learn

Current best practices in pediatric psychopharmacology across a range of psychiatric disorders

Evidence-based medication strategies for ADHD, mood disorders, anxiety disorders, psychotic disorders, and autism spectrum disorders

Approaches to monitoring treatment response, managing side effects, and preventing adverse events

Guidance on polypharmacy, special populations, and treatment-resistant cases

Updates on novel pharmacologic agents and emerging therapeutic trends in child and adolescent psychiatry

Event Details

Event: American Academy of Child and Adolescent Psychiatry Pediatric Psychopharmacology Update Institute 2025

Format: Live virtual program with interactive Q&A sessions and on-demand access to recorded content

Program Highlights: Expert-led lectures, real-world case discussions, and high-yield prescribing tips

Topics Covered: Psychopharmacology principles, disorder-specific medication management, safety protocols, and integration with psychosocial interventions

Who Should AttendChild and adolescent psychiatrists, general psychiatrists, pediatricians, psychiatric nurse practitioners, psychologists, and other healthcare professionals involved in prescribing or managing psychiatric medications for young patients.
Why AttendThis course provides a focused, up-to-date, and clinically applicable review of pediatric psychopharmacology. Attendees will leave equipped with the knowledge, skills, and confidence to make informed prescribing decisions that maximize therapeutic benefits while minimizing risks in the treatment of children and adolescents.
 
+ Topics:
Bipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp3
Bipolar Disorder in Youth What is, What Isn’t, and how to Treat it.mp4
Depression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp3
Depression in North America What Works in Clinical Trials Versus What Works for the Teenager in Your Office.mp4
Is Child Psychiatry Ready for the Master Observational Trial.mp3
Is Child Psychiatry Ready for the Master Observational Trial.mp4
Obsessive-Compulsive Disorder Pharmacology in 2025 Reviewing Basics and Dispelling Traditional Lore.mp3
Obsessive-Compulsive Disorder Pharmacology in 2025 Reviewing Basics and Dispelling Traditional Lore.mp4
Pediatric Drug Development in the United States.mp3
Pediatric Drug Development in the United States.mp4
Psychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp3
Psychopharmacologic and Psychosocial Interventions to Address Mental Health Challenges in Autism.mp4
Psychopharmacology for ODD Treating the Horse or the Cart.mp3
Psychopharmacology for ODD Treating the Horse or the Cart.mp4
Psychopharmacology in (not for) Autism Spectrum Disorder An Update.mp3
Psychopharmacology in (not for) Autism Spectrum Disorder An Update.mp4
Q&A Discussion.mp3
Q&A Discussion.mp4
Q&A Panel Discussion 1.mp3
Q&A Panel Discussion 1.mp4
Q&A Panel Discussion 2.mp3
Q&A Panel Discussion 2.mp4
Q&A Panel Discussion 3.mp3
Q&A Panel Discussion 3.mp4
Tics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp3
Tics Tactics Navigating Pharmacotherapy in Pediatric Tourette’s Syndrome.mp4
Updates in ADHD Psychopharmacology.mp3
Updates in ADHD Psychopharmacology.mp4